The Worst Is Over for Generic-Drug Stocks

  • 📰 WSJ
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Heard on the Street: There are signs that the generic-drug industry’s long stock-market nightmare is ending, CGrantWSJ writes

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 98. in İD

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Generic-drug industry is riddled with price-fixing schemes, investigators sayWhat started as an antitrust lawsuit brought by states over just two drugs in 2016 is said to have exploded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs. Probably a legally mandated formula how much drug companies can raise price above net cost is needed. ellewoodsgolfs This doesn’t surprise me. I pay $1400 for a 90-day supply of my generic colitis drug. The consumers have been feeling this for quite some time.
Sumber: latimes - 🏆 11. / 82 Baca lebih lajut »